Place-based Mapping in EAS Listeners
Primary Purpose
Cochlear Implant
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
place-based mapping
default mapping
Sponsored by

About this trial
This is an interventional treatment trial for Cochlear Implant
Eligibility Criteria
Cochlear implant participants
Inclusion Criteria:
- 18-80 years of age at implantation, identify English as native language, Medical Electronics (MED-EL) array recipient, and a postoperative unaided detection threshold of less than or equal to 65 decibel (dB) hearing level (HL) at 125 Hz
Exclusion Criteria:
- Report or present with a cognitive delay or impairment
Normal-hearing controls
Inclusion Criteria:
- 18-80 years of age at time of testing, unaided detection thresholds of 35 dB HL or better from 500-4000 Hz, identify English as native language
Exclusion Criteria:
- Report or present with a cognitive delay or impairment
Sites / Locations
- UNC ENT at Carolina CrossingRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
Default
Place-based
Arm Description
The default frequency filters assigned by the clinical software
Frequency filters adjusted to align with the cochlear place frequency
Outcomes
Primary Outcome Measures
Monaural perception over time
Monaural perception (e.g., word recognition in quiet) will be assessed at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals.
Binaural hearing abilities over time
Binaural hearing abilities (e.g., spatial release from masking) will be assessed at defined intervals (e.g., 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals.
Secondary Outcome Measures
Perceived abilities over time
Perceived abilities will be assessed with questionnaires (e.g., Speech, Spatial, and Qualities of hearing scale; SSQ) at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). A subject indicates his/her perceived abilities for each question on the SSQ using a Likert scale, with a range of 0-10 (with 10 indicating better perceived abilities). Responses will be compared between group over the study intervals.
Full Information
NCT ID
NCT04722042
First Posted
January 19, 2021
Last Updated
October 4, 2023
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
1. Study Identification
Unique Protocol Identification Number
NCT04722042
Brief Title
Place-based Mapping in EAS Listeners
Official Title
Place-based Mapping in Electric-acoustic Stimulation Listeners
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 23, 2021 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Purpose: Investigate monaural and binaural hearing in electric-acoustic stimulation (EAS) users with place-based versus default maps.
Participants: Cochlear implant recipients and normal-hearing listeners Procedures (methods): This is a prospective, longitudinal investigation of the monaural and binaural outcomes (such as speech perception, spatial hearing, and/or subjective benefit) of cochlear implant recipients listening with different programs. The programs will incorporate different patient and device variables to determine the effect on cochlear implant recipient outcomes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cochlear Implant
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Subjects will be randomized to one of two groups.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Default
Arm Type
Other
Arm Description
The default frequency filters assigned by the clinical software
Arm Title
Place-based
Arm Type
Experimental
Arm Description
Frequency filters adjusted to align with the cochlear place frequency
Intervention Type
Other
Intervention Name(s)
place-based mapping
Intervention Description
Adjusting the electric frequency filters to align with the cochlear place frequency
Intervention Type
Other
Intervention Name(s)
default mapping
Intervention Description
Default frequency filter assignments
Primary Outcome Measure Information:
Title
Monaural perception over time
Description
Monaural perception (e.g., word recognition in quiet) will be assessed at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals.
Time Frame
Up to 12 months post-activation
Title
Binaural hearing abilities over time
Description
Binaural hearing abilities (e.g., spatial release from masking) will be assessed at defined intervals (e.g., 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals.
Time Frame
Up to 12 months post-activation
Secondary Outcome Measure Information:
Title
Perceived abilities over time
Description
Perceived abilities will be assessed with questionnaires (e.g., Speech, Spatial, and Qualities of hearing scale; SSQ) at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). A subject indicates his/her perceived abilities for each question on the SSQ using a Likert scale, with a range of 0-10 (with 10 indicating better perceived abilities). Responses will be compared between group over the study intervals.
Time Frame
Up to 12 months post-activation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Cochlear implant participants
Inclusion Criteria:
18-80 years of age at implantation, identify English as native language, Medical Electronics (MED-EL) array recipient, and a postoperative unaided detection threshold of less than or equal to 65 decibel (dB) hearing level (HL) at 125 Hz
Exclusion Criteria:
Report or present with a cognitive delay or impairment
Normal-hearing controls
Inclusion Criteria:
18-80 years of age at time of testing, unaided detection thresholds of 35 dB HL or better from 500-4000 Hz, identify English as native language
Exclusion Criteria:
Report or present with a cognitive delay or impairment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Margaret Dillon, AuD, PhD
Phone
919-966-5251
Email
mdillon@med.unc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret T Dillon, AuD, PhD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kevin D Brown, MD, PhD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNC ENT at Carolina Crossing
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27517
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Margaret Dillon, AuD, PhD
First Name & Middle Initial & Last Name & Degree
Margaret Dillon, AuD, PhD
First Name & Middle Initial & Last Name & Degree
Kevin Brown, MD, PhD
First Name & Middle Initial & Last Name & Degree
Emily Buss, PhD
First Name & Middle Initial & Last Name & Degree
Meredith Rooth, AuD
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.
IPD Sharing Time Frame
beginning 9 to 36 months following publication
IPD Sharing Access Criteria
Investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.
Learn more about this trial
Place-based Mapping in EAS Listeners
We'll reach out to this number within 24 hrs